ClinicalTrials.Veeva

Menu

Establishment and Clinical Validation of New Technologies for Accurate Screening of Colorectal Cancer Based on Multi-omics

Zhejiang University logo

Zhejiang University

Status

Not yet enrolling

Conditions

Colorectal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04913233
2021-0199

Details and patient eligibility

About

Background:

The current screening techniques for colorectal cancer include colonoscopy, fecal occult blood, and high-risk factor questionnaires. However, the colorectal cancer screening technology that has been widely used at present cannot take into account sensitivity and specificity, and the tumor detection rate is low.

The purpose of research:

  1. Build a new type of population colorectal cancer precision screening technology program;
  2. Improve the detection rate of colorectal cancer in the population by new methods (compared with the existing domestic advanced technology) by ≥20%, and improve the specificity of colorectal cancer screening by ≥15% without significantly reducing the sensitivity.

Enrollment

9,000 estimated patients

Sex

All

Ages

40 to 74 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Age: 40-74 years old

Exclusion criteria

  1. Combine severe disorders to make it unsuitable for colonoscopy
  2. Combine other tumors
  3. Mental and behavioral abnormalities do not cooperate with the screener
  4. Researchers believe that other reasons are not suitable for enrollment

Trial contacts and locations

3

Loading...

Central trial contact

Yanqin Huang; Ying Yuan

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems